ISSN: 0973-7510

E-ISSN: 2581-690X

Review Article | Open Access
Gursimran Kaur Mohi1, Bhavana Yadav2 , Shaunik Singh3 and Nisha Thakur1
1Department of Virology, Postgraduate Institute of Medical Education and Research, PGIMER, Sector-12, Chandigarh, India.
2Department of Microbiology, Gian Sagar Medical College and Hospital, Rajpura, Punjab, India.
3Drug Safety Physician (Medical Specialist) Continuum, Chandigarh, India.
Article Number: 8023 | © The Author(s). 2023
J Pure Appl Microbiol. 2023;17(1):69-79.
Received: 24 August 2022 | Accepted: 28 January 2023 | Published online: 02 March 2023
Issue online: March 2023

Paediatric population is the high-risk segment for the infection of COVID-19 due to weak immune status and low compliance to COVID-19 prevention protocols. The first dose of vaccination for the paediatric population is started in the fifth phase of vaccination, after the vaccination was administered to health workers, elderly individuals, and young adults. Present article aims to analyse the status, trends, and challenges in the implementation of the paediatric vaccination for COVID-19 and provide recommendations that could be taken under consideration by healthcare authorities while designing the second and third vaccination protocols for the paediatric population. Relevant articles published by various journals related to paediatric COVID-19 vaccination were searched from the different databases and analysed for the current status of vaccination, trends, challenges, compliance level, implementation hurdles, and other relevant information. Limited research is available in the paediatric domain for the COVID-19 vaccination. Few vaccines are approved for the paediatric population in India, including the Covaxin, ZyCoV-D, Corbevax and Covovax. It is recommended that the vaccination trials should be accelerated by the government agencies to make COVID vaccines available from other indigenous manufacturers. It is also recommended that the COVID-19 prevention protocol should be made in such a manner that children find that interesting and like to follow them.


Paediatric, COVID, Vaccine, ZyCoV-D and Covaxin

Article Metrics

Article View: 33

Share This Article

© The Author(s) 2023. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.